{"id":"https://openalex.org/W1871023","doi":null,"title":"Identifying appropriate subjects for abuse liability studies using prestudy pharmacological testing.","display_name":"Identifying appropriate subjects for abuse liability studies using prestudy pharmacological testing.","publication_year":1999,"publication_date":"1999-01-01","ids":{"openalex":"https://openalex.org/W1871023","mag":"1871023","pmid":"https://pubmed.ncbi.nlm.nih.gov/10519736"},"language":"en","primary_location":{"id":"pmid:10519736","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/10519736","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"The Canadian journal of clinical pharmacology = Journal canadien de pharmacologie clinique","raw_type":"Clinical Trial"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5113463357","display_name":"U. Busto","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I1338135719","display_name":"Centre for Addiction and Mental Health","ror":"https://ror.org/03e71c577","country_code":"CA","type":"healthcare","lineage":["https://openalex.org/I1338135719"]}],"countries":["CA"],"is_corresponding":false,"raw_author_name":"U E Busto","raw_affiliation_strings":["Facylty of Pharmacy, Behavioural Research Department, Centre for Addiction and Mental Health Addiction--Research Foundation Site, Toronto, Ontario, Canada. ubusto@arf.org"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Facylty of Pharmacy, Behavioural Research Department, Centre for Addiction and Mental Health Addiction--Research Foundation Site, Toronto, Ontario, Canada. ubusto@arf.org","institution_ids":["https://openalex.org/I1338135719"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5062487017","display_name":"Laurie A. Zawertailo","orcid":"https://orcid.org/0000-0002-4547-1565","observed_orcids":["https://orcid.org/0000-0002-4547-1565"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"L A Zawertailo","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5103489619","display_name":"Howard L. Kaplan","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"H L Kaplan","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"last","author":{"id":"https://openalex.org/A5013791504","display_name":"Edward M. Sellers","orcid":"https://orcid.org/0000-0002-0669-2373","observed_orcids":["https://orcid.org/0000-0002-0669-2373"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"E M Sellers","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":0.0,"has_fulltext":false,"cited_by_count":9,"citation_normalized_percentile":{"value":7.348e-05,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":88,"max":93},"biblio":{"volume":"6","issue":"2","first_page":"103","last_page":"10"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10043","display_name":"Substance Abuse Treatment and Outcomes","score":0.38839998841285706,"subfield":{"id":"https://openalex.org/subfields/2713","display_name":"Epidemiology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10043","display_name":"Substance Abuse Treatment and Outcomes","score":0.38839998841285706,"subfield":{"id":"https://openalex.org/subfields/2713","display_name":"Epidemiology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10576","display_name":"Opioid Use Disorder Treatment","score":0.3522999882698059,"subfield":{"id":"https://openalex.org/subfields/2739","display_name":"Public Health, Environmental and Occupational Health"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10056","display_name":"Neurotransmitter Receptor Influence on Behavior","score":0.0568000003695488,"subfield":{"id":"https://openalex.org/subfields/2804","display_name":"Cellular and Molecular Neuroscience"},"field":{"id":"https://openalex.org/fields/28","display_name":"Neuroscience"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/drug-abuse-liability","display_name":"drug abuse liability","score":0.8100000023841858},{"id":"https://openalex.org/keywords/subject-choice","display_name":"participant selection","score":0.7739999890327454},{"id":"https://openalex.org/keywords/prescreening","display_name":"prescreening","score":0.8339999914169312},{"id":"https://openalex.org/keywords/subjective-drug-effects","display_name":"subjective drug effects","score":0.8270000219345093},{"id":"https://openalex.org/keywords/hydromorphone","display_name":"hydromorphone","score":0.8820000290870667},{"id":"https://openalex.org/keywords/secobarbital","display_name":"secobarbital","score":0.9440000057220459},{"id":"https://openalex.org/keywords/hydrocodone","display_name":"hydrocodone","score":0.9829999804496765},{"id":"https://openalex.org/keywords/placebo-response","display_name":"placebo response","score":0.6320000290870667},{"id":"https://openalex.org/keywords/pupil-size","display_name":"pupil size","score":0.7139999866485596},{"id":"https://openalex.org/keywords/psychomotor-impairment","display_name":"psychomotor impairment","score":0.9909999966621399},{"id":"https://openalex.org/keywords/benzodiazepine-receptor-agonists","display_name":"benzodiazepine receptor agonists","score":0.8370000123977661},{"id":"https://openalex.org/keywords/carbamates","display_name":"carbamates","score":0.7590000033378601},{"id":"https://openalex.org/keywords/amphetamine","display_name":"amphetamine","score":0.9419999718666077},{"id":"https://openalex.org/keywords/selective-serotonin-reuptake-inhibitors","display_name":"selective serotonin reuptake inhibitors","score":0.9890000224113464}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.8169858455657959},{"id":"https://openalex.org/C2779158186","wikidata":"https://www.wikidata.org/wiki/Q303646","display_name":"Hydromorphone","level":4,"score":0.7339303493499756},{"id":"https://openalex.org/C2778140631","wikidata":"https://www.wikidata.org/wiki/Q2026938","display_name":"Opiate","level":3,"score":0.680281937122345},{"id":"https://openalex.org/C3018251022","wikidata":"https://www.wikidata.org/wiki/Q3184856","display_name":"Abuse liability","level":3,"score":0.6635301113128662},{"id":"https://openalex.org/C2908647359","wikidata":"https://www.wikidata.org/wiki/Q2625603","display_name":"Population","level":2,"score":0.6390891075134277},{"id":"https://openalex.org/C2776389719","wikidata":"https://www.wikidata.org/wiki/Q411441","display_name":"Hydrocodone","level":5,"score":0.5307174921035767},{"id":"https://openalex.org/C40010229","wikidata":"https://www.wikidata.org/wiki/Q3184856","display_name":"Substance abuse","level":2,"score":0.4923187494277954},{"id":"https://openalex.org/C118552586","wikidata":"https://www.wikidata.org/wiki/Q7867","display_name":"Psychiatry","level":1,"score":0.3632228374481201},{"id":"https://openalex.org/C42219234","wikidata":"https://www.wikidata.org/wiki/Q131130","display_name":"Anesthesia","level":1,"score":0.3625239133834839},{"id":"https://openalex.org/C2780035454","wikidata":"https://www.wikidata.org/wiki/Q8386","display_name":"Drug","level":2,"score":0.34621185064315796},{"id":"https://openalex.org/C2781063702","wikidata":"https://www.wikidata.org/wiki/Q427523","display_name":"Opioid","level":3,"score":0.2684253454208374},{"id":"https://openalex.org/C2776029756","wikidata":"https://www.wikidata.org/wiki/Q407535","display_name":"Oxycodone","level":4,"score":0.26833850145339966},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.16291514039039612},{"id":"https://openalex.org/C99454951","wikidata":"https://www.wikidata.org/wiki/Q932068","display_name":"Environmental health","level":1,"score":0.0},{"id":"https://openalex.org/C170493617","wikidata":"https://www.wikidata.org/wiki/Q208467","display_name":"Receptor","level":2,"score":0.0}],"mesh":[{"descriptor_ui":"D000328","descriptor_name":"Adult","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D004353","descriptor_name":"Drug Evaluation, Preclinical","qualifier_ui":"Q000379","qualifier_name":"methods","is_major_topic":true},{"descriptor_ui":"D005260","descriptor_name":"Female","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008297","descriptor_name":"Male","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008875","descriptor_name":"Middle Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D011569","descriptor_name":"Psychiatric Status Rating Scales","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D011619","descriptor_name":"Psychotropic Drugs","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":true},{"descriptor_ui":"D012107","descriptor_name":"Research Design","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D019966","descriptor_name":"Substance-Related Disorders","qualifier_ui":"Q000523","qualifier_name":"psychology","is_major_topic":true}],"locations_count":2,"locations":[{"id":"pmid:10519736","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/10519736","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"The Canadian journal of clinical pharmacology = Journal canadien de pharmacologie clinique","raw_type":"Clinical Trial"},{"id":"mag:1871023","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/10519736","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":null,"is_accepted":false,"is_published":false,"raw_source_name":"PubMed","raw_type":null}],"best_oa_location":null,"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","score":0.9537000060081482,"display_name":"Good health and well-being"}],"study_designs":[],"awards":[{"id":"https://openalex.org/G4174243057","display_name":"PHARMACOGENETIC RISK FACTORS IN DRUG ABUSE--CYP VARIANTS","funder_award_id":"R01DA006889","funder_id":"https://openalex.org/F4320337347","funder_display_name":"National Institute on Drug Abuse"}],"funders":[{"id":"https://openalex.org/F4320337347","display_name":"National Institute on Drug Abuse","ror":"https://ror.org/00fq5cm18"}],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W2042996833","https://openalex.org/W2002208697","https://openalex.org/W2077620252","https://openalex.org/W1987802056","https://openalex.org/W2073961263","https://openalex.org/W1970209789","https://openalex.org/W2415174389","https://openalex.org/W2004030834","https://openalex.org/W1536080995","https://openalex.org/W2160813852"],"abstract_inverted_index":{"Drug":[0],"abuse":[1,44,71,195],"liability":[2,72,196],"testing":[3],"usually":[4],"involves":[5],"a":[6,24,46,219,231,238],"subject":[7],"population":[8,29,232,275,286],"of":[9,30,48,76,129,133,157,197,230,233,263,269,291],"individuals":[10],"who":[11,86,149,169],"are":[12,39],"current":[13],"or":[14],"former":[15],"drug":[16,43,96,239,256,266,284],"abusers.":[17],"To":[18,125],"determine":[19],"whether":[20],"choosing":[21],"subjects":[22,63,85,135,148,168,247,272,281],"from":[23,136,267,273,282],"wider":[25],"and":[26,57,93,118,167,190,200,211,253,258],"more":[27],"diverse":[28],"nondrug":[31,220,234],"abusers":[32,235],"results":[33,75,145],"in":[34,174],"subjective":[35,155,255],"response":[36],"patterns":[37],"that":[38,81,147,287],"pharmacologically":[40,102],"associated":[41],"with":[42,142,237],"liability,":[45],"series":[47],"studies":[49,79],"were":[50,83,87,140,150,159],"conducted":[51],"using":[52,218],"the":[53,58,115,122,127,134,137,175,194,227,261,283],"prescription":[54,212],"opiate":[55,116,213],"hydromorphone":[56,138,158,173],"barbiturate":[59,123],"secobarbital":[60],"to":[61,90,152,162,165,172,180,215,226,245,251,259],"prescreen":[62,246],"before":[64],"their":[65,249],"acceptance":[66],"into":[67],"large":[68],"multidrug,":[69],"multidose":[70],"studies.":[73],"The":[74,144],"these":[77,130],"prescreening":[78,176,185,294],"show":[80],"there":[82],"some":[84],"not":[88],"able":[89],"report":[91,153,254],"consistently":[92,178],"reliably":[94],"relevant":[95],"effects,":[97,257],"even":[98],"though":[99],"they":[100],"received":[101],"active":[103,265],"doses":[104],"as":[105,111],"measured":[106],"by":[107],"objective":[108],"indexes":[109],"such":[110],"pupil":[112],"diameter":[113],"for":[114,121,248],"study":[117,177],"psychomotor":[119],"impairment":[120],"study.":[124],"test":[126],"consistency":[128],"results,":[131],"several":[132,277],"screening":[139],"retested":[141],"hydrocodone.":[143],"demonstrate":[146],"unable":[151,161],"positive":[154],"effects":[156,262],"also":[160],"respond":[163],"appropriately":[164,171],"hydrocodone,":[166],"responded":[170,179],"another":[181],"opiate.":[182],"Using":[183],"this":[184,274,292],"methodology":[186],"has":[187,276],"allowed":[188],"sensitive":[189],"reliable":[191],"data":[192],"on":[193],"benzodiazepine":[198],"agonists":[199],"partial":[201],"agonists,":[202],"barbiturates,":[203],"carbamate":[204],"compounds,":[205],"amphetamines,":[206],"selective":[207],"serotonin":[208],"reuptake":[209],"inhibitors":[210],"compounds":[214],"be":[216],"generated":[217],"abusing":[221,240,285],"population.":[222],"In":[223],"conclusion,":[224],"due":[225],"relative":[228],"heterogeneity":[229],"compared":[236],"population,":[241],"it":[242],"is":[243],"necessary":[244],"ability":[250],"detect":[252],"distinguish":[260],"an":[264],"those":[268],"placebo.":[270],"Selecting":[271],"advantages":[278],"over":[279],"selecting":[280],"outweigh":[288],"any":[289],"inconvenience":[290],"simple":[293],"methodology.":[295]},"counts_by_year":[{"year":2018,"cited_by_count":1},{"year":2017,"cited_by_count":1},{"year":2013,"cited_by_count":1},{"year":2012,"cited_by_count":1}],"updated_date":"2026-11-04T10:54:05.112534","created_date":"2016-06-24T00:00:00"}